Oxygen Therapy Market Size, Share & Trends Report

Oxygen Therapy Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices, Static, Dynamic), By Application, By End-use, And Segment Forecasts, 2018 - 2024

  • Published Date: Mar, 2018
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-829-9
  • Format: Electronic (PDF)
  • Historical Data: 2014
  • Number of Pages: 125

Report Overview

The global oxygen therapy market size was estimated at USD 7.09 billion in 2015 and is anticipated to grow at a CAGR of 11.1% over the forecast period. Increasing incidences of chronic respiratory diseases coupled with rising demand for home healthcare are the major drivers of the market.

U.S. oxygen therapy market

As per the National Institutes of Health (NIH), nearly 12 million adults have been diagnosed with COPD in the U.S. and 120,000 people die each year. According to the data published by the Global Asthma Network (GAN), asthma affects nearly 334 million people worldwide. The increasing patient population is expected to boost the demand for these products. This consequent increase in demand is expected to drive the industry over the coming years.

In addition, the advent of the technologically advanced oxygen source and delivery devices, which offers efficient patient care, is expected to boost the industry. These advancements include flow regulating devices, sensors, and conjunction of delivery devices with pulse dose meters. The adoption of O2 therapy is increasing owing to the potential benefits such as controlled flow, efficient dosing, faster response rates, and greater durability & reliability. The aforementioned factors are anticipated to propel industry expansion.

Rising popularity and adoption of on-demand and continuous Portable Oxygen Concentrators (POC) in a wide range of applications such as emergency medicine is also expected to fuel the demand over the future years. This surge is attributable to global competitors entering the market, demand for the portable technology by consumers, and the clinical urgency for greater mobility support for the geriatric population. The business is anticipated to increase owing to continuous innovation and resulting in more efficient units and reduced prices.

Product Insights

As of 2015, oxygen source equipment held the substantial share of the product segment and accounted for 66.1% of the overall market owing to its high availability and utilization in the form of O2 concentrators, compressed gas systems, cylinders, and liquid oxygen. Moreover, these devices serve as the primary source and initiation step for O2 therapy, acting as a key contributing factor towards the overall growth of the industry.

Oxygen concentrators in the oxygen source equipment segment are anticipated to grow at a lucrative rate. The transportable concentrators are expected to present significant growth potential owing to their applicability in various medical emergencies, usage in ambulances, rails, and aircraft; therefore, contributing towards the potential demand for this segment.

The oxygen delivery devices segment is anticipated to exhibit a lucrative growth owing to the availability of a wide range of delivery devices pertaining to different patients’ inspiratory and physiological needs. Additionally, the potential advantages associated such as constant O2 flow, elimination of complicated masks, variable pressure demand, and flow dilution are expected to facilitate demand over the coming years.

Oxygen masks segment is expected to be growing at a steady growth rate as a consequence of these masks being an indispensable part of the O2 delivery system, resulting in increased consumption, thereby serving as a key contributing factor towards market growth over the future period. Additionally, these devices facilitate accurate O2 concentration delivery, sustained flow & pressure, and patient comfort, which are anticipated to increase the segment demand.

Application Insights

Chronic Obstructive Pulmonary Disorder (COPD) segment dominated the market with a significant share of 38.13% owing to the increasing incidence of COPD. As per the estimates reported by the WHO, there are approximately 65 million people suffering from COPD and is the fifth leading cause of mortality. The rising prevalence of COPD is driving the clinical urgency for the treatment of COPD thereby contributing to the expansion of the business.

Asthma held the second-largest share of the industry based on application. The evolving O2 treatment modalities such as high flow nasal cannula delivery of O2 in the emergency care and non-invasive ventilation for the treatment of asthma are expected to present the industry with future growth opportunities in this segment during the study period.

Sleep apnea segment is anticipated to witness exponential growth in the future owing to the utilization of nocturnal oxygen therapy as an alternative for the treatment of obstructive sleep apnea. The growing prevalence of this disorder and supplemental O2 administration in conjunction with CPAP devices for improved patient outcomes is responsible for driving the demand for this segment over the next few years.

Respiratory Distress Syndrome segment is anticipated to exhibit a moderate growth rate during the future period owing to rising prevalence of respiratory distress syndrome in premature birth. The dearth of effective treatment alternatives is anticipated to drive the clinical urgency for the treatment of RDS, thereby presenting the segment with key growth opportunities in the near future.

End-use Insights

Hospitals & clinics segment is expected to grow at a steady rate over the forecast period. Technologically advanced medical equipment is being used extensively in hospitals to improve the point of care. Hospital segment is anticipated to grow at a steady rate owing to the use of O2 therapy equipment and other associated supplies in hospitals.

Moreover, hospital settings present a wide range of facilities coupled with controlled environments that drive the preference of patients with severe disorders, thereby boosting the growth of this segment. The aforementioned factors are expected to contribute to steady market growth.

Home healthcare held a substantial share of the end-use segment in terms of revenue in 2015. Growing population base having a low mobility profile and favorable reimbursement policies are contributing to the growth of this segment. The rising incorporation of Long Term Oxygen Therapy (LTOT) equipment in home settings are anticipated to boost the demand for these products over the forecast period.

Large-scale availability of a wide range of home O2 therapy equipment is expected to widen the base for growth during the forecast period. All these factors are anticipated to provide the industry with potential growth opportunities.

Regional Insights

North America dominated the industry and was valued at USD 2,844 million in 2015. North America accounted for the largest share of the global O2 therapy market owing to high R&D investments and trials pertaining to O2 therapy. For instance, the British Medical Research Council in collaboration with North American Nocturnal Oxygen Therapy conducted research to study the efficacy of long-term O2 therapy.

Global oxygen therapy market

Moreover, the increasing popularity of hyperbaric oxygen therapy and Topical Wound Oxygen therapy (TWO) over this region is contributing towards the market demand. Additionally, as a result of urbanization and occupational hazards over this region, it poses a high risk of contraction of respiratory disorders, which is anticipated to augment the market during the forecast period.

Asia Pacific is anticipated to witness exponential growth during the forecast period. The market is driven by high R&D investment by global players as well as increasing commercialization of O2 therapy equipment developed by these players.

Moreover, the urgent need for the development of new systems and replacement & upgrading of medical infrastructure is anticipated to address the business with lucrative growth opportunities over the forecast period. The perpetual technological innovations coupled with the rising collaboration of global players and their expansion of distribution networks are propelling the growth of O2 therapy in this region.

Key Companies & Market Share Insights

The industry is developing due to the growing demand for greater comfort, controlled flow rate as required by the patient, enhanced patient response, and reduced wastage of gas. The O2 therapy market is highly competitive in nature with a limited number of players having a high level of dominance over the overall revenue share.

Key players in this industry are GE Healthcare, Invacare Corporation, CareFusion Corporation, Smiths Medical, HERSILL S.L., Fisher & Paykel Healthcare Limited, Philips Respironics Inc., DeVillbiss Healthcare, Tecno-Gaz Industries, Allied Healthcare Products, Inc., Teleflex Incorporated, Chart Industries, and MAQUET Medical Systems.

Companies are employing strategies such as collaborations, mergers & acquisitions, new product launch and technological advancements for sustaining the competition, and better market penetration. For instance, in May 2016, Inogen launched its Inogen One G4 portable oxygen concentrator used in homecare settings. This helps Inogen to extend its product portfolio and is expected to contribute to market share over the forecast period.

The increase in industry competition can be credited to the growing number of players, frequent product approvals, and efficient distribution agreements. As a result, competitive rivalry in the industry is anticipated to be high over the forecast period.   

Oxygen Therapy Market Report Scope

Report Attribute

Details

Market size value in 2020

USD 11.9 billion

Revenue forecast in 2024

USD 18.2 billion

Growth Rate

CAGR of 11.1% from 2016 to 2024

Base year for estimation

2015

Historical data

2014

Forecast period

2016 - 2024

Quantitative units

Revenue in USD million and CAGR from 2016 to 2024

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

The U.S.; Canada; The U.K.; Germany; China; Japan; India; Brazil; Mexico; South Africa

Key companies profiled

CareFusion Corporation; GE Healthcare; Tecno-Gaz Industries; Hersill; Philips Respironics, Inc.; DeVilbiss Healthcare; MAQUET Medical Systems; Smiths Medical; Allied Healthcare Products, Inc.; Fisher & Paykel Healthcare Limited; Teleflex Incorporated

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2024. For the purpose of this study, Grand View Research has segmented the global oxygen therapy market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2024)

    • Oxygen Source Equipment

      • Oxygen Cylinders

      • Oxygen Concentrators

      • Liquid Oxygen Devices

      • PAP Devices

    • Oxygen Delivery Devices

      • Oxygen Masks

      • Nasal Cannula

      • Venturi Masks

      • Non-rebreather Masks

      • Bag Valve Masks

      • CPAP Masks

      • Others

  • Application Outlook (Revenue, USD Million, 2014 - 2024)

    • Chronic Obstructive Pulmonary Disease

    • Asthma

    • Obstructive Sleep Apnea

    • Respiratory Distress Syndrome

    • Cystic Fibrosis

    • Pneumonia

    • Others

  • End-Use Outlook (Revenue, USD Million, 2014 - 2024)

    • Home Healthcare

    • Hospitals

  • Regional Outlook (Revenue, USD Million, 2014 - 2024)

    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • The Middle East and Africa

      • South Africa

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities